Ovarian function in female survivors of childhood malignancies

Pediatric Hematology and Oncology

Volumn 30, Issue 4, 2013, Pages 328-335

  El Shalakany, Amr H ^a   Ali, Mohamed S ^a   Abdelmaksoud, Abeer A ^b   El Ghany, Shereen Abd ^b   Hasan, Enam A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Cancer therapy (fertility); Chemotherapy; Endocrinology

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FEMALE FERTILITY; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MENARCHE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MULTIMODALITY CANCER THERAPY; ORGAN SIZE; OVARY FUNCTION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTI-MULLERIAN HORMONE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; NEOPLASMS; NEUROBLASTOMA; OVARY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVORS; WILMS TUMOR;

EID: 84876118599     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2013.778927     Document Type: Article

References (46)

1. Bhatia S, Landier W. Evaluating survivors of pediatric cancer. Cancer J. 2005;11(4):340-354
2. Oeffinger KC, Mertens AC, Hudson MM, et a.l. Health care of young adult survivors of childhood cancer: A report fromthe Childhood Cancer Survivor Study. Ann Fam Med. 2004; 2(1): 61-70
3. Green DM, Sklar CA, Boice Jr. JD, et a.l. Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2374-2381
4. Green DM, Kawashima T, StovallM, et a.l. Fertility of female survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol. 2009;27:2677-2685
5. Wallace WH, Anderson RA, Irvine D.S. Fertility preservation for young patients with cancer: Who is at risk and what can be offered? Lancet Oncol. 2005;6:209-218
6. Chemaitilly W, Mertens AC, Mitby P, et a.l. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91:1723-1728
7. Gracia CR, SammelMD, Freeman E, et a.l. Impact of cancer therapies on ovarian reserve. Fertil Steril. 2012;97:134-140.e1
8. Ethics Committee of the American Society for ReproductiveMedicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622-1628
9. Hagen CP, Aksglaede L, Sørensen K, et a.l. Serum levels of anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab. 2010;95:5003-5010
10. La Marcaa A, Sighinolfia G, Giulinia S, et a.l. Normal serum concentrations of anti-Mullerian hormone in women with regular menstrual cycles. Reproductive BioMedicine Online Volume 21, Issue 4, October 2010;463-469. http://dx.doi.org/10.1016/j.rbmo.2010.05
11. Andersen CY, Schmidt KT, Kristensen SG, et a.l. Concentrations of AMHand inhibin-B in relation to follicular diameter in normal human small antral follicles. Hum Reprod. 2010;25:1282-1287
12. van Rooij IA, Broekmans FJ, Scheffer GJ, et a.l. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertil Steril. 2005;83:979-987
13. Kelsey TW, Wright P, Nelson SM, et a.l. A validated model of serum anti-mullerian hormone from conception tomenopause. PLoS ONE. 2011;6:e22024
14. Broekmans FJ, Visser JA, Laven JS, et a.l. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19:340-347. http://www.advancedfertility.com/amh-fertility-test.htm
15. Bath LE,Wallace WH, ShawMP, et a.l. Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003;18:2368-2374
16. Lie Fong S, Laven JS, Hakvoort-Cammel FG, et a.l. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone. Hum Reprod. 2009;24:982-990
17. Larsen EC, Muller J, Schmiegelow K, et a.l. Reduced ovarian function in long-term survivors of radiation- And chemotherapy-treated childhood cancer. JClinEndocrinolMetab. 2003;88:5307-5314
18. Landgren BM, Collins A, Csemiczky G, et a.l. Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab. 2004;89:2763-2769
19. Freeman EW, SammelMD, Gracia CR, et a.l. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril. 2005;83:383-392
20. Welt CK,McNicholl DJ, Taylor AE, Hall J.E. Female reproductive aging ismarked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab. 1999;84:105-111
21. vanRooij IA, Broekmans FJ, Scheffer GJ, et a.l. Serumantimullerian hormone levels best reflect the reproductive declinewith age in normalwomenwith proven fertility: A longitudinal study. Fertil Steril. 2005;83:979-987
22. RuessML, Kline J, Santos R, et a.l. Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol. 1996;174:624-627
23. Sharara FI, McClamrock H.D. The effect of aging on ovarian volume measurements in infertile women. Obstet Gynecol. 1999;94:57-60
24. Bancsi LF, Broekmans FJ, Mol BW, et a.l. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure tobecomepregnant after in vitro fertilization: A metaanalysis. Fertil Steril. 2003;79:1091-1100
25. John K, Kippley S. The Couple to Couple League. In: Cincinnati, OH, e.d. The Art of Natural Family Planning. 4th e.d. 1996; 92. ISBN 0-926412-13-2
26. thefreedictionary.com > oligomenorrhea This dictionary, in turn, is citing: Gale Encyclopedia of Medicine. 2008
27. Traggiaci C, Stanhope R. Disorders of pubertal development: Best Pract Res Clin Obstet Gynaecol. 2003;17(1):41-56
28. Giacobbe M,Mendes Pinto-Neto A, Simoes Costa-Paiva LH, et a.l.The usefulness of ovarian volume, antral follicle count and age as predictors of menopausal status. Climacteric. 2004;7:255-260
29. Fallat ME, Hutter J. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics. 2008;121(5): e1461 - e1469
30. Gurgan T, Salman C, Demirol A. Pregnancy and assisted reproduction techniques in men and women after cancer treatment. Placenta. 2008;29(Suppl B):152-159
31. Lie Fong S, Lugtenburg PJ, Schipper I, et a.l. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematologicalmalignancies.HumReprod. 2008;23(3):674-678
32. Paolucci G,Mancim AF, Di Caro A. Iatrogenic gonadal dysfunction is females in pediatric oncology. In: Bohiglion F and De Aloysio D. Drugs and Reangten Induced Menopause. Bologna: Monduzzi. 1991: 45
33. MullerHL, Klinkhammer-SchalkeM, Seelbach-Göbel B, et a.l.Gonadal function of young adults after therapy ofmalignancies during childhood or adolescence. Eur J Pediatr. 1996;155(9):763-769
34. Mills JL, Fears TR, Robison LL, et a.l. Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukemia. J Pediatr. 1997;131(4):598-602
35. Chow EJ, Friedman DL, Yasui Y, et a.l. Timing of menarche among survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2008;50(4):854-858
36. Lie Fong S, Laven JS, Hakvoort-Cammel FG, et a.l. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Hum Reprod. 2009;24(4):982-990
37. Kristensen SL, Ramlau-Hansen CH, Andersen CY, et a.l.The association between circulating levels of anti-mullerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women. Fertil Steril. 2012;97:779-785
38. Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2007;134:196-201
39. Li HW,WongCY, YeungWS, et a.l. Serumanti-mullerian hormone level is not altered inwomenusing hormonal contraceptives. Contraception. 2011;83:582-585
40. Larsen EC, Muller J, Schmiegelow K, et a.l. Reduced ovarian function in long-term survivors of radiation- And chemotherapy-treated childhood cancer. JClinEndocrinolMetab. 2003;88:5307-5314
41. Wilson G, Fleming R, Galloway P, et a.l. Serum Anti-Mullerian hormone (AMH) concentrations in infants and children. Endocrine Abstracts. 2006: 11 P721. http://www.endocrineabstracts.org/ea/0011/ea0011p721.htm.
42. Faddy M.J. Follicle dynamics during ovarian ageing. Mol Cell Endocrinol. 2000;163(1-2):43-48
43. Brydøy M, Foss̊a SD, DahlO, Bjøro T.Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol. 2007;46(4): 480-489
44. Shebl O, Ebner T, Sir A, et a.l. Age-related distribution of basal serumAMH level in women of reproductive age and a presumably healthy cohort. Fertil Steril. 2011;95(2):832-834
45. El-Samahy MH, El-Beblawy NMS. Lymphoma in the pediatric age group 20 years experience in Ain Shams University Children's Hospital Egypt J. Pediatr. 2000;4(16):499-511
46. Bath LE,Wallace WH, ShawMP, et a.l. Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003;18:2368-2374